+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Graves Disease Market - Global Forecast 2025-2030- Product Image
Graves Disease Market - Global Forecast 2025-2030- Product Image
Sale

Graves Disease Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674290
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Graves Disease Market is evolving rapidly, presenting new challenges and opportunities for organizations aiming to improve patient outcomes, streamline operational efficiency, and respond to evolving healthcare demands. Senior decision-makers must address both the complexity of autoimmune pathophysiology and the shifting expectations for precision in diagnostics and treatment to secure a competitive position.

Market Snapshot: Graves Disease Market Overview

The Graves Disease Market grew from USD 641.22 million in 2024 to USD 677.20 million in 2025. It is expected to continue growing at a CAGR of 5.82%, reaching USD 900.53 million by 2030. This market expansion highlights increasing adoption of advanced diagnostics, the integration of novel immunomodulatory therapies, and escalating demand across global healthcare infrastructures.

Scope & Segmentation

This report delivers a comprehensive segmentation framework spotlighting all critical factors influencing strategic decisions in the Graves Disease Market. Market participants benefit from a clear breakdown of approaches and opportunities across the care continuum.

  • Diagnosis: Includes blood tests for Free T4 and T3 levels, thyroid-stimulating hormone concentrations, TSH receptor antibody analysis, imaging methods such as radioactive iodine uptake and thyroid ultrasound, and clinical physical examination.
  • Treatment Type: Encompasses antithyroid medications, beta-blocker regimens, and radioactive iodine therapy.
  • Age Group: Addresses adult, elderly, and pediatric populations with tailored protocols.
  • Route of Administration: Covers intravenous and oral medication routes.
  • Distribution Channel: Evaluates hospital pharmacies, online pharmacies, and retail pharmacies for medication access.
  • Regions: Analyzes the Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (countries such as United Kingdom, Germany, UAE, Saudi Arabia, South Africa, among others), and Asia-Pacific (including China, India, Japan, Australia, and more).
  • Leading Companies: Examines strategies from Abbott Laboratories, Novartis AG, Siemens Healthineers AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., among other key industry players.

Key Takeaways for Decision-Makers

  • Precision diagnostics and personalized intervention models are fueling the adoption of new therapeutic and monitoring approaches for Graves disease.
  • Stakeholder pressure for optimized care pathways is prompting a focus on digital health solutions, enabling enhanced remote monitoring and access to specialist expertise.
  • Pharmaceutical innovation is shifting toward targeting underlying immune dysregulation, not just symptom reduction, driving higher expectations for improved safety and efficacy profiles.
  • Collaborative partnerships between diagnostics and pharmaceuticals, as well as integration with digital platforms, are enabling organizations to unlock new market segments and enhance patient engagement.
  • Regulatory harmonization and regional investments are accelerating access to cutting-edge technologies and therapies, but disparities remain in underserved areas requiring customized strategies.
  • Supply chain agility and scenario planning have become core to organizational resilience in the face of evolving policy landscapes and procurement risks.

Tariff Impact on the Graves Disease Market

United States tariff changes introduced in 2025 have directly influenced supply chain dynamics, increasing procurement costs for diagnostic reagents and medications. Market participants are responding by developing domestic production partnerships, seeking secondary sources, and collaborating with contract manufacturers to safeguard supply continuity. Healthcare providers are also optimizing inventory and workflow strategies to mitigate extended lead times for crucial test components and therapies.

Methodology & Data Sources

This report integrates exhaustive secondary research of published literature, regulatory filings, and health data with primary interviews from endocrinologists, clinical laboratory and supply chain leaders, and policy experts. Internal peer review and triangulation of verified data ensure robust and actionable insights for every stakeholder.

Primary Keyword: Graves Disease Market

Why This Report Matters

  • Enables senior leaders to anticipate evolving trends, guiding resource allocation and innovation strategies in high-impact segments.
  • Empowers organizations to benchmark against industry frontrunners, identify growth opportunities, and navigate regulatory and operational uncertainties effectively.
  • Supports strategic planning with validated, transparent insights into market shifts, supply chain risks, and diagnostic and therapeutic advances.

Conclusion

This analysis delivers the insights senior decision-makers need to chart growth, resilience, and improved patient outcomes. Integrating segmentation depth, regional analysis, and policy impact, the report offers a foundation for confident, forward-looking strategies in Graves disease care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of targeted biologic therapies aiming at B-cell modulation for refractory Graves disease management
5.2. Integration of wearable thyroid function monitoring devices enabling real time TSH tracking and patient engagement
5.3. Expansion of teleendocrinology platforms facilitating remote diagnosis and treatment adjustments for Graves disease patients
5.4. Regulatory approval of novel small molecule TSH receptor antagonists expanding non invasive treatment options
5.5. Growth in combination therapy protocols merging antithyroid drugs with immunomodulators to reduce relapse rates
5.6. Emergence of patient centric digital health applications supporting symptom logging and medication adherence in Graves disease
5.7. Clinical adoption of high intensity focused ultrasound as a non surgical alternative for Graves ophthalmopathy management
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Graves Disease Market, by Diagnosis
8.1. Introduction
8.2. Blood Tests
8.2.1. Free T4 & T3 Levels
8.2.2. Thyroid-stimulating Hormone (TSH) Levels
8.2.3. TSH Receptor Antibodies (TSH-RAb)
8.3. Imaging Tests
8.3.1. Radioactive Iodine Uptake
8.3.2. Thyroid Ultrasound
8.4. Physical Examination
9. Graves Disease Market, by Treatment Type
9.1. Introduction
9.2. Antithyroid Medications
9.3. Beta-Blockers
9.4. Radioactive Iodine Therapy
10. Graves Disease Market, by Age Group
10.1. Introduction
10.2. Adult
10.3. Elderly
10.4. Pediatric
11. Graves Disease Market, by Route Of Administration
11.1. Introduction
11.2. Intravenous
11.3. Oral
12. Graves Disease Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.4. Retail Pharmacies
13. Americas Graves Disease Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Graves Disease Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Graves Disease Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. AdvanceCor GmbH
16.3.3. Cadila Pharmaceuticals Limited
16.3.4. CORONA Remedies Limited
16.3.5. Daxia Healthcare Pvt Ltd.
16.3.6. Eris Lifesciences Ltd
16.3.7. F. Hoffmann-La Roche Ltd.
16.3.8. Immunovant, Inc. by Roivant Sciences Ltd.
16.3.9. LGM Pharma
16.3.10. Macleods Pharmaceuticals Ltd.
16.3.11. Merck KGaA
16.3.12. Novartis AG
16.3.13. Pfizer Inc.
16.3.14. Salvavidas Pharmaceutical Pvt. Ltd.
16.3.15. Siemens Healthineers AG
16.3.16. Steris Healthcare Pvt Ltd
16.3.17. Sun Pharmaceutical Industries Ltd
16.3.18. Synmedic Laboratories by Dhanuka Laboratories Limited
16.3.19. Teva Pharmaceutical Industries Ltd.
16.3.20. Thermo Fisher Scientific Inc.
16.3.21. Wellona Pharma
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. GRAVES DISEASE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GRAVES DISEASE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GRAVES DISEASE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GRAVES DISEASE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GRAVES DISEASE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GRAVES DISEASE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. GRAVES DISEASE MARKET: RESEARCHAI
FIGURE 26. GRAVES DISEASE MARKET: RESEARCHSTATISTICS
FIGURE 27. GRAVES DISEASE MARKET: RESEARCHCONTACTS
FIGURE 28. GRAVES DISEASE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GRAVES DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GRAVES DISEASE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GRAVES DISEASE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GRAVES DISEASE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GRAVES DISEASE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GRAVES DISEASE MARKET SIZE, BY FREE T4 & T3 LEVELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GRAVES DISEASE MARKET SIZE, BY FREE T4 & T3 LEVELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GRAVES DISEASE MARKET SIZE, BY THYROID-STIMULATING HORMONE (TSH) LEVELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GRAVES DISEASE MARKET SIZE, BY THYROID-STIMULATING HORMONE (TSH) LEVELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GRAVES DISEASE MARKET SIZE, BY TSH RECEPTOR ANTIBODIES (TSH-RAB), BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GRAVES DISEASE MARKET SIZE, BY TSH RECEPTOR ANTIBODIES (TSH-RAB), BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GRAVES DISEASE MARKET SIZE, BY RADIOACTIVE IODINE UPTAKE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GRAVES DISEASE MARKET SIZE, BY RADIOACTIVE IODINE UPTAKE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GRAVES DISEASE MARKET SIZE, BY THYROID ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GRAVES DISEASE MARKET SIZE, BY THYROID ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GRAVES DISEASE MARKET SIZE, BY PHYSICAL EXAMINATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GRAVES DISEASE MARKET SIZE, BY PHYSICAL EXAMINATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GRAVES DISEASE MARKET SIZE, BY ANTITHYROID MEDICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GRAVES DISEASE MARKET SIZE, BY ANTITHYROID MEDICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GRAVES DISEASE MARKET SIZE, BY BETA-BLOCKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GRAVES DISEASE MARKET SIZE, BY BETA-BLOCKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GRAVES DISEASE MARKET SIZE, BY RADIOACTIVE IODINE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GRAVES DISEASE MARKET SIZE, BY RADIOACTIVE IODINE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GRAVES DISEASE MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GRAVES DISEASE MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GRAVES DISEASE MARKET SIZE, BY ELDERLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GRAVES DISEASE MARKET SIZE, BY ELDERLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GRAVES DISEASE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GRAVES DISEASE MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GRAVES DISEASE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GRAVES DISEASE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GRAVES DISEASE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GRAVES DISEASE MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GRAVES DISEASE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GRAVES DISEASE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GRAVES DISEASE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GRAVES DISEASE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GRAVES DISEASE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GRAVES DISEASE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES GRAVES DISEASE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES GRAVES DISEASE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 93. CANADA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 94. CANADA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 95. CANADA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 96. CANADA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 97. CANADA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 98. CANADA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 99. CANADA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 100. CANADA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 101. CANADA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 102. CANADA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 103. CANADA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 104. CANADA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 105. CANADA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. CANADA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. MEXICO GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 108. MEXICO GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 109. MEXICO GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 110. MEXICO GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 111. MEXICO GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 112. MEXICO GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 113. MEXICO GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 114. MEXICO GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 115. MEXICO GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 116. MEXICO GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 117. MEXICO GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 118. MEXICO GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 119. MEXICO GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. MEXICO GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. GERMANY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 180. GERMANY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 181. GERMANY GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 182. GERMANY GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 183. GERMANY GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 184. GERMANY GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 185. GERMANY GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 186. GERMANY GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 187. GERMANY GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 188. GERMANY GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 189. GERMANY GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 190. GERMANY GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 191. GERMANY GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. GERMANY GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. FRANCE GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 194. FRANCE GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 195. FRANCE GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 196. FRANCE GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 197. FRANCE GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 198. FRANCE GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 199. FRANCE GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 200. FRANCE GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 201. FRANCE GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 202. FRANCE GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 203. FRANCE GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 204. FRANCE GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 205. FRANCE GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. FRANCE GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. ITALY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 222. ITALY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 223. ITALY GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 224. ITALY GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 225. ITALY GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 226. ITALY GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 227. ITALY GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 228. ITALY GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 229. ITALY GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 230. ITALY GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 231. ITALY GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 232. ITALY GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 233. ITALY GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. ITALY GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. SPAIN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 236. SPAIN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 237. SPAIN GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 238. SPAIN GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 239. SPAIN GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 240. SPAIN GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 241. SPAIN GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 242. SPAIN GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 243. SPAIN GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 244. SPAIN GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 245. SPAIN GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 246. SPAIN GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 247. SPAIN GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. SPAIN GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. DENMARK GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 292. DENMARK GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 293. DENMARK GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 294. DENMARK GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 295. DENMARK GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 296. DENMARK GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 297. DENMARK GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 298. DENMARK GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 299. DENMARK GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 300. DENMARK GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 301. DENMARK GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 302. DENMARK GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 303. DENMARK GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. DENMARK GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. QATAR GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 320. QATAR GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 321. QATAR GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 322. QATAR GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 323. QATAR GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 324. QATAR GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 325. QATAR GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 326. QATAR GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 327. QATAR GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 328. QATAR GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 329. QATAR GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 330. QATAR GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 331. QATAR GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. QATAR GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. FINLAND GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 334. FINLAND GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 335. FINLAND GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 336. FINLAND GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 337. FINLAND GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 338. FINLAND GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 339. FINLAND GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 340. FINLAND GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 341. FINLAND GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 342. FINLAND GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 343. FINLAND GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 344. FINLAND GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 345. FINLAND GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 346. FINLAND GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 347. SWEDEN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 348. SWEDEN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 349. SWEDEN GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
TABLE 350. SWEDEN GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
TABLE 351. SWEDEN GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
TABLE 352. SWEDEN GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
TABLE 353. SWEDEN GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Graves Disease market report include:
  • Abbott Laboratories
  • AdvanceCor GmbH
  • Cadila Pharmaceuticals Limited
  • CORONA Remedies Limited
  • Daxia Healthcare Pvt Ltd.
  • Eris Lifesciences Ltd
  • F. Hoffmann-La Roche Ltd.
  • Immunovant, Inc. by Roivant Sciences Ltd.
  • LGM Pharma
  • Macleods Pharmaceuticals Ltd.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Salvavidas Pharmaceutical Pvt. Ltd.
  • Siemens Healthineers AG
  • Steris Healthcare Pvt Ltd
  • Sun Pharmaceutical Industries Ltd
  • Synmedic Laboratories by Dhanuka Laboratories Limited
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific Inc.
  • Wellona Pharma

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 677.2 Million
Forecasted Market Value ( USD ) by 2030 $ 900.53 Million
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Graves' Disease (Overactive Thyroid) - Global Strategic Business Report - Product Image

Graves' Disease (Overactive Thyroid) - Global Strategic Business Report

  • Report
  • 386 Pages
  • Global
From
Graves' Disease - Pipeline Insight, 2025 - Product Image

Graves' Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Graves' Orbitopathy- Pipeline Insight, 2025 - Product Image

Graves' Orbitopathy- Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Goitre Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035 - Product Image

Goitre Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035

  • Report
  • Global
From
Carbimazole Market - Global Forecast 2025-2030 - Product Image

Carbimazole Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From

About the Graves Disease Market

Graves Disease is a type of autoimmune disorder that affects the thyroid gland. It is the most common cause of hyperthyroidism, a condition in which the thyroid produces too much of the hormone thyroxine. Symptoms of Graves Disease include weight loss, increased appetite, rapid heart rate, and bulging eyes. Treatment typically involves medications to reduce the production of thyroxine, as well as radioactive iodine therapy to destroy the thyroid gland. Allergy and Immunology is a medical specialty that focuses on the diagnosis and treatment of allergies and immune system disorders. Allergy and Immunology specialists are trained to diagnose and treat Graves Disease, as well as other autoimmune disorders. They may also provide advice on lifestyle changes to help manage the condition. Companies in the Graves Disease market include AbbVie, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.